Circulating biomarkers in classical Hodgkin lymphoma
Plattel, Wouter Johannes
DOI:
10.33612/diss.97631424
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2019
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Plattel, W. J. (2019). Circulating biomarkers in classical Hodgkin lymphoma. Rijksuniversiteit Groningen.
https://doi.org/10.33612/diss.97631424
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.
Circulating biomarkers in
classical Hodgkin lymphoma
Cover design and layout: © evelienjagtman.com Printed by: Gildeprint
Circulating biomarkers in
classical Hodgkin lymphoma
Proefschrift
ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen
op gezag van de
rector magnificus prof. dr. C. Wijmenga en volgens besluit van het College voor Promoties.
De openbare verdediging zal plaatsvinden op woensdag 16 oktober 2019 om 16.15 uur
door
Wouter Johannes Plattel geboren op 26 januari 1985
te Marum
Beoordelingscommissie Prof. dr. M.J. Kersten Prof. dr. D. de Jong Prof. dr. G. de Haan
Contents
Chapter 1 Introduction and review of circulating biomarkers in Hodgkin Lymphoma
In preparation
7
PART 1
Chapter 2 Plasma Thymus and Activation-Regulated Chemokine as an early response marker in classical Hodgkin lymphoma
Haematologica. 2012 Mar;97(3):410-5
31
Chapter 3 Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC
Br J Haematol. 2016 Dec;175(5):868-875
53
Chapter 4 Interim TARC versus interim 18F-FDG-PET in classical Hodgkin
lymphoma response evaluation Submitted
71
PART 2
Chapter 5 The role of microRNAs in Hodgkin lymphoma In MicroRNAs in Medicine, C. H. Lawrie (Ed.). 2013
83 Chapter 6 Pre-analytical, analytical and post-analytical challenges in
circulating miRNA studies
99 Chapter 7 Circulating miRNAs in serum of patients with classical Hodgkin
Lymphoma
117
SUMMARY AND DISCUSSION
Chapter 8 Summary, general discussion and future perspectives 133
Chapter 9 Nederlandse samenvatting 149
APPENDICES Dankwoord List of publications Curriculum Vitae 161 169 171
